{"id":13052,"date":"2024-08-23T06:04:37","date_gmt":"2024-08-23T04:04:37","guid":{"rendered":"https:\/\/valintermed.com\/?p=13052"},"modified":"2024-08-23T06:04:37","modified_gmt":"2024-08-23T04:04:37","slug":"spinalnaya-myshechnaya-atrofiya-tipa-2","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/spinal-myocardial-atrophy-type-2\/","title":{"rendered":"Spinal muscular atrophy type 2"},"content":{"rendered":"
<\/div>\n

Spinal muscular atrophy type 2 (SMA type 2) is an inherited disorder that belongs to the spectrum of primary diseases of the anterior horn of the spinal cord. The main cause of SMA is a deficiency of the protein SMN (survival motor neuron), which is necessary for the health and function of motor neurons responsible for muscle movement. This leads to progressive muscle weakness, atrophy, and dysfunction of skeletal muscles. The disease manifests itself in early childhood, and its clinical signs include difficulties in physical development, as well as impaired motor skills, such as sitting and walking. SMA type 2 is characterized by a more favorable course compared to other forms of spinal muscular atrophy, but without timely intervention it can lead to significant limitations in physical activity and deterioration in the quality of life of patients.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n